MedTrace Logo

Carboxytherapy for Periorbital Dark Circles

NCT04745078 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-11-04

No results posted yet for this study

Summary

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Conditions

  • Periorbital Disorder

Interventions

OTHER

Caboxy30

carboxy30 to periorbital dark halos

OTHER

Caboxy60

carboxy60 to periorbital dark halos

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Ossama H Roushdy, MD · University of Alexandria

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2021-04-01
Completion
2021-05-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745078 on ClinicalTrials.gov